company background image
543064 logo

Suven Pharmaceuticals BSE:543064 Stock Report

Last Price

₹1.10k

Market Cap

₹279.9b

7D

-1.9%

1Y

50.2%

Updated

08 Jan, 2025

Data

Company Financials

Suven Pharmaceuticals Limited

BSE:543064 Stock Report

Market Cap: ₹279.9b

543064 Stock Overview

Operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. More details

543064 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends0/6

Risk Analysis

Earnings have declined by 1.4% per year over past 5 years


My Notes

Capture your thoughts, links and company narrative

Suven Pharmaceuticals Limited Competitors

Emcure Pharmaceuticals

NSEI:EMCURE

₹273.9b

Pfizer

NSEI:PFIZER

₹246.2b

Concord Biotech

NSEI:CONCORDBIO

₹236.7b

GlaxoSmithKline Pharmaceuticals

BSE:500660

₹374.0b

Price History & Performance

Summary of share price highs, lows and changes for Suven Pharmaceuticals
Historical stock prices
Current Share Price₹1,102.10
52 Week High₹1,359.00
52 Week Low₹586.10
Beta1.35
1 Month Change-15.73%
3 Month Change-7.27%
1 Year Change50.20%
3 Year Change106.41%
5 Year Changen/a
Change since IPO556.01%

Recent News & Updates

Recent updates

Shareholder Returns

543064IN PharmaceuticalsIN Market
7D-1.9%-1.4%-1.1%
1Y50.2%33.6%15.0%

Return vs Industry: 543064 exceeded the Indian Pharmaceuticals industry which returned 35.8% over the past year.

Return vs Market: 543064 exceeded the Indian Market which returned 16% over the past year.

Price Volatility

Is 543064's price volatile compared to industry and market?
543064 volatility
543064 Average Weekly Movement3.8%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.1%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 543064 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 543064's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1989n/aSudhir Singhsuvenpharm.com

Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was founded in 1989 and is based in Hyderabad, India.

Suven Pharmaceuticals Limited Fundamentals Summary

How do Suven Pharmaceuticals's earnings and revenue compare to its market cap?
543064 fundamental statistics
Market cap₹279.91b
Earnings (TTM)₹2.43b
Revenue (TTM)₹9.61b

115.1x

P/E Ratio

29.1x

P/S Ratio

Is 543064 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
543064 income statement (TTM)
Revenue₹9.61b
Cost of Revenue₹4.07b
Gross Profit₹5.54b
Other Expenses₹3.11b
Earnings₹2.43b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 12, 2025

Earnings per share (EPS)9.55
Gross Margin57.65%
Net Profit Margin25.29%
Debt/Equity Ratio0.4%

How did 543064 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 03:48
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Suven Pharmaceuticals Limited is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rohit BhatBatlivala & Karani Securities India Pvt. Ltd.
Nikhil ShettyBP Wealth Management Private Limited
Vinod T.P.Geojit Financial Services Ltd.